首页> 美国卫生研究院文献>Mediators of Inflammation >Levels of Malondialdehyde and Superoxide Dismutase inSubclinical Hyperthyroidism
【2h】

Levels of Malondialdehyde and Superoxide Dismutase inSubclinical Hyperthyroidism

机译:丙二醛和超氧化物歧化酶水平亚临床甲亢

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We aimed to determine whether patients with subclinical hyperthyroidism (SH) are subject to oxidative stress. Twenty-two women and 8 men having endogenous subclinical hyperthyroidism for a duration of at least 6 months, and 21 women and 9 men healthy controls were included in this study. We measured the level of plasma malondialdehyde, as one of the lipid peroxidation markers, and the activity of erythrocyte superoxide dismutase, which is an antioxidant enzyme. The activity of erythrocyte superoxide dismutase and plasma malondialdehyde levels were found to be significantly higher in subjects with subclinical hyperthyroidism than the control group (P < .01). The results of this study suggest that oxidative stress and antioxidative response could be increased in patients having subclinical hyperthyroidism.
机译:我们旨在确定亚临床甲状腺功能亢进症(SH)患者是否遭受氧化应激。本研究包括22例内源性亚临床甲状腺功能亢进症持续至少6个月的女性和8名男性,以及21名女性和9名男性的健康对照。我们测量了血浆丙二醛(作为脂质过氧化标记之一)的水平,以及红细胞超氧化物歧化酶(一种抗氧化酶)的活性。发现亚临床甲状腺功能亢进患者的红细胞超氧化物歧化酶活性和血浆丙二醛水平明显高于对照组(P <.01)。这项研究的结果表明,亚临床甲状腺功能亢进症患者的氧化应激和抗氧化反应可能会增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号